Drug Pipeline

Itepekimab (SAR440340) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
0
Recruiting
5
Phase 3
1
Top Sponsors
8
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT06834360
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 overall status: "Recruiting" → "Active Not Recruiting"
2026-06-03 NCT06834360
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 date change Primary completion moved earlier: 2027-01-08 -> 2026-11-06
2026-06-03 NCT06834360
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 date change Completion moved earlier: 2027-12-13 -> 2027-10-11
2026-05-28 NCT07424144
An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in…		 Trial sites expanded: 10 -> 15 locations
2026-05-21 NCT06834347
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 overall status: "Recruiting" → "Active Not Recruiting"
2026-05-21 NCT06834347
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 Enrollment increased: 210 -> 231 participants
2026-05-21 NCT06834347
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 date change Primary completion moved earlier: 2027-01-08 -> 2026-10-14
2026-05-21 NCT06834347
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab…		 date change Completion moved earlier: 2027-12-13 -> 2027-09-16
Active Studies by Phase
Phase 3
5
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07484230 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… Chronic Rhinosinusitis With Nasal Polyps Not Yet Recruiting
NCT06208306 A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants… Chronic Obstructive Pulmonary Disease Active, Not Recruiting
NCT06834347 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… Chronic Rhinosinusitis With Nasal Polyps Active, Not Recruiting
NCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in… Chronic Rhinosinusitis With Nasal Polyps Enrolling by Invitation
NCT06834360 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab… Chronic Rhinosinusitis With Nasal Polyps Active, Not Recruiting
Phase 2
NCT06691113 A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab… Chronic Rhinosinusitis Without Nasal Polyps Active, Not Recruiting
Sponsors Running Itepekimab (SAR440340) Trials
Sanofi (6)
Disease Areas
COPD (1)
Get alerts when Itepekimab (SAR440340) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free